Malignant Eccrine Porocarcinoma in Finland During 2007 to 2017
DOI:
https://doi.org/10.2340/00015555-3718Keywords:
eccrine porocarcinoma, incidence, survivalAbstract
Malignant eccrine porocarcinoma is a rare skin adnexal cancer arising from the sweat glands. Little is known about the epidemiology and incidence of eccrine porocarcinoma. This registry-based study examined the epidemiology and incidence data for eccrine porocarcinoma from the Finnish Cancer Registry. The study included all persons diagnosed with eccrine porocarcinoma in 2007 to 2017. There were 69 cases in the study period; 34 (49%) male and 35 (51%) female patients. Mean age at diagnosis was 75.5 years. Incidence for men was 0.06 per 100,000 person-years and for women 0.04 per 100,000 person-years adjusted for age according to the World Standard Population. Incidence increased with age. There was one eccrine porocarcinoma-specific death among the 69 patients. The incidence of eccrine porocarcinoma in Finland is therefore low. The mean age at time of diagnosis and the location of eccrine porocarcinoma are consistent with previous reports. The survival of patients with eccrine porocarcinoma is high.
Downloads
References
Shaw M, McKee PH, Lowe D, Black MM. Malignant eccrine poroma: a study of twenty-seven cases. Br J Dermatol 1982; 107: 675-680.
DOI: https://doi.org/10.1111/j.1365-2133.1982.tb00527.x
Robson A, Greene J, Ansari N, Kim B, Seed PT, McKee PH, et al. Eccrine porocarcinoma (malignant eccrine poroma): a clinicopathologic study of 69 cases. Am J Surg Pathol 2001; 25: 710-720.
DOI: https://doi.org/10.1097/00000478-200106000-00002
Belin E, Ezzedine K, Stanislas S, Lalanne N, Beylot-Barry M, Taieb A, et al. Factors in the surgical management of primary eccrine porocarcinoma: prognostic histological factors can guide the surgical procedure. Br J Dermatol 2011; 165: 985-989.
DOI: https://doi.org/10.1111/j.1365-2133.2011.10486.x
Nazemi A, Higgins S, Swift R, In G, Miller K, Wysong A. Eccrine porocarcinoma: new insights and a systematic review of the literature. Dermatol Surg 2018; 44: 1247-1261.
DOI: https://doi.org/10.1097/DSS.0000000000001566
Riera-Leal L, Guevara-Gutierrez E, Barrientos-Garcia JG, Madrigal-Kasem R, Briseno-Rodriguez G, Tlacuilo-Parra A. Eccrine porocarcinoma: epidemiologic and histopathologic characteristics. Int J Dermatol 2015; 54: 580-586.
DOI: https://doi.org/10.1111/ijd.12714
Stam H, Lohuis PJ, Zupan-Kajcovski B, Wouters MW, van der Hage JA, Visser O. Increasing incidence and survival of a rare skin cancer in the Netherlands. A population-based study of 2,220 cases of skin adnexal carcinoma. J Surg Oncol 2013; 107: 822-827.
DOI: https://doi.org/10.1002/jso.23331
Pinkus H, Mehregan AH. Epidermotropic eccrine carcinoma. A case combining features of eccrine poroma and Paget's dermatosis. Arch Dermatol 1963; 88: 597-606.
DOI: https://doi.org/10.1001/archderm.1963.01590230105015
Mishima Y, Morioka S. Oncogenic differentiation of the intraepidermal eccrine sweat duct: eccrine poroma, poroepithelioma and porocarcinoma. Dermatologica 1969; 138: 238-250.
DOI: https://doi.org/10.1159/000253989
Salih AM, Kakamad FH, Essa RA, Rauf GM, S AM, H MS, et al. Porocarcinoma: a systematic review of literature with a single case report. Int J Surg Case Rep 2017; 30: 13-16.
DOI: https://doi.org/10.1016/j.ijscr.2016.10.051
Behbahani S, Malerba S, Karanfilian KM, Warren CJ, Alhatem A, Samie FH. Demographics and outcomes of eccrine porocarcinoma: results from the National Cancer Database. Br J Dermatol 2020; 183: 161-163.
DOI: https://doi.org/10.1111/bjd.18874
Sawaya JL, Khachemoune A. Poroma: a review of eccrine, apocrine, and malignant forms. Int J Dermatol 2014; 53: 1053-1061.
DOI: https://doi.org/10.1111/ijd.12448
Pukkala E, Engholm G, Hojsgaard Schmidt LK, Storm H, Khan S, Lambe M, et al. Nordic Cancer Registries - an overview of their procedures and data comparability. Acta Oncol 2018; 57: 440-455.
DOI: https://doi.org/10.1080/0284186X.2017.1407039
Segi M, Fujisaku S. Cancer mortality for selected sites in 24 countries (1950-1957): Department of Public Health, Tohoku University School of Medicine; 1960.
Pace M, Lanzieri G, Glickman M, Zupani? T. Revision of the European Standard Population: report of Eurostat's task force: Publications Office of the European Union; 2013.
Goon PKC, Gurung P, Levell NJ, Subramanian P, Yong ASW, Lee KYC, et al. Eccrine porocarcinoma of the skin is rising in incidence in the East of England. Acta Derm Venereol 2018; 98: 991-992.
DOI: https://doi.org/10.2340/00015555-3000
Mehregan AH, Hashimoto K, Rahbari H. Eccrine adenocarcinoma. A clinicopathologic study of 35 cases. Arch Dermatol 1983; 119: 104-114.
DOI: https://doi.org/10.1001/archderm.1983.01650260012008
Tolkachjov SN, Schmitt AR, Muzic JG, Weaver AL, Baum CL. Incidence and clinical features of rare cutaneous malignancies in Olmsted County, Minnesota, 2000 to 2010. Dermatol Surg 2017; 43: 116-124.
DOI: https://doi.org/10.1097/DSS.0000000000000936
Avraham JB, Villines D, Maker VK, August C, Maker AV. Survival after resection of cutaneous adnexal carcinomas with eccrine differentiation: risk factors and trends in outcomes. J Surg Oncol 2013; 108: 57-62.
DOI: https://doi.org/10.1002/jso.23346
Sahi H, Their J, Gissler M, Koljonen V. Merkel cell carcinoma treatment in Finland in 1986-2016 - a real-world data study. Cancers (Basel) 2020; 12: 1224.
DOI: https://doi.org/10.3390/cancers12051224
Goto K, Takai T, Fukumoto T, Anan T, Kimura T, Ansai S, et al. CD117 (KIT) is a useful immunohistochemical marker for differentiating porocarcinoma from squamous cell carcinoma. J Cutan Pathol 2016; 43: 219-226.
DOI: https://doi.org/10.1111/cup.12632
Kurisu Y, Tsuji M, Yasuda E, Shibayama Y. A case of eccrine porocarcinoma: usefulness of immunostain for s-100 protein in the diagnoses of recurrent and metastatic dedifferentiated lesions. Ann Dermatol 2013; 25: 348-351.
DOI: https://doi.org/10.5021/ad.2013.25.3.348
Nakazawa T, Kondo T, Sato E, Motosugi U, Niu D, Mochizuki K, et al. Subcutaneous porocarcinoma clinically presenting as a soft tissue tumor. J Cutan Pathol 2015; 42: 897-902.
Published
How to Cite
License
Copyright (c) 2021 Anna-Stiina Meriläinen, Eero Pukkala, Tom Böhling, Virve Koljonen
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
